ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1547	National Cancer Institute	Html	en	Breast Cancer Prevention (PDQ®)–Patient Version	Expert-reviewed information summary about factors that may increase the risk of developing breast cancer and about research aimed at the prevention of this disease.	oral contraceptives 0.44629 estrogen 0.514255 cancer prevention trials 0.467827 aromatase inhibitors 0.469347 protective factors 0.454834 following PDQ summaries 0.44582 PDQ cancer information 0.511331 estrogen receptor modulators 0.455223 cancer increases 0.459313 clinical trials 0.534737 lymph nodes 0.44919 cancer information summary 0.4886 breast cancer prevention 0.555818 risk factors 0.504832 lower risk 0.453128 cancer risk assessment 0.507159 cancer risk factor 0.484227 NCI PDQ cancer 0.469096 high risk 0.467476 invasive breast cancer 0.511126 hormone replacement therapy 0.452766 endometrial cancer 0.448602 main risk factor 0.448463 women 0.533999	estrogen levels 0.494589 Risk Assessment Tool 0.449387 cancer risk factors 0.481509 cancer protective factor 0.460417 Cancer Information Service 0.454292 personal history 0.453732 prevention clinical trials 0.453685 breast tissue 0.513715 Prevention Editorial Board 0.450607 premenopausal women 0.44709 National Cancer Institute 0.48923 cancer death 0.445453 postmenopausal women 0.494383 BRCA2 genes 0.445277 breast cancer risk 0.572283 Cancer Care page 0.450952 breast cancer 0.955273 breast disease 0.469281 longer her breast 0.466997 cancer clinical trials 0.457937 cancer information summaries 0.456631 comprehensive cancer information 0.456301 risk 0.656483 new breast cancers 0.479317	CLICK HERE
1578	National Cancer Institute	Html	en	Salivary Gland Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of salivary gland cancer.	treatment 0.350503 cancer cells 0.273747 salivary gland tumors 0.252711 body 0.202362 Recurrent salivary gland 0.246617 PDQ cancer information 0.209396 clinical trial search 0.221183 National Cancer Institute 0.225088 clinical trials 0.502843 clinical trial 0.428553 fast neutron radiation 0.275402 patients 0.211575	salivary glands 0.27815 small salivary gland 0.219313 major salivary gland 0.219682 salivary gland cancer 0.977675 cancer clinical trials 0.23079 lymph node 0.201663 radiation therapy 0.594263 salivary gland cancers 0.255838 information 0.215378 diagnose salivary gland 0.246491 Minor salivary gland 0.204078 neutron radiation therapy 0.270686	CLICK HERE
1594	National Cancer Institute	Html	en	Gallbladder Cancer Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of gallbladder cancer.	Primary gallbladder cancer 0.47032 bile ducts 0.484867 tissue 0.379314 body 0.404589 Gallbladder Cancer Treatment 0.453363 PDQ cancer information 0.441195 clinical trial search 0.374973 bile duct 0.37352 Endoscopic stent placement 0.366691 nearby lymph nodes 0.402642 cancer information summary 0.414802 clinical trial 0.522846 breast cancer prevention 0.364901 liver 0.416883 gallbladder surgery 0.402266 gallbladder stores 0.412552 patients 0.384079 blood vessels 0.366084 metastatic gallbladder cancer 0.515618 Unresectable cancer 0.362347 treatment clinical trial 0.366014 NCI PDQ cancer 0.38278 radiation therapy 0.532352 Treatment Editorial Board 0.368907	small intestine 0.483884 treatment 0.503531 gallbladder cancer 0.938706 transhepatic biliary drainage 0.367562 new cancer treatments 0.372521 NCI-supported cancer 0.364603 cancer cells 0.513548 Cancer Information Service 0.372954 common bile duct 0.365877 treatment clinical trials 0.389845 gallbladder cancer cells 0.455848 National Cancer Institute 0.416909 new treatment 0.406145 External radiation therapy 0.364544 stage gallbladder cancer 0.491411 ) layer. 0.384877 clinical trials 0.742882 Cancer Care page 0.364553 Blood. The cancer 0.370595 cancer research process 0.366097 cancer clinical trials 0.40814 tumor 0.374261 cancer information summaries 0.371259 comprehensive cancer information 0.371502	CLICK HERE
1855	National Cancer Institute	Html	es	Tratamiento del melanoma (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del melanoma.	Balch CM 0.20184 from melanoma 0.197443 cutaneous melanoma 0.929676 uveal melanoma 0.269501 lymph node dissection 0.257644 Selective Lymphadenectomy Trial 0.185912 melanomas cutáneos 0.23269 high-risk melanoma 0.256841 resected malignant melanoma 0.200679 Melanoma Surgical Trial 0.417684 Malignant Melanoma Cooperative 0.296451 Organization Melanoma Program 0.292871 KIT-mutated melanoma 0.201689 Cancer Malignant Melanoma 0.300034 Cascinelli N 0.153801 high-risk limb melanoma 0.296133 fase iii 0.291304 with cutaneous melanoma 0.209012 Estados Unidos 0.170558 Melanoma Cooperative Group 0.292176 metastatic melanoma 0.516921 patients with 0.293744 Health Organization Melanoma 0.292338 cutaneous malignant melanoma 0.277012 melanoma ocular uveal 0.44805	linfadenectomía regional 0.216986 untreated metastatic melanoma 0.198744 melanoma with 0.28157 Melanoma Programme 0.206923 estadio iv 0.160146 lymph node melanoma 0.221901 ganglio linfático centinela 0.421022 Multicenter Selective Lymphadenectomy 0.162584 Melanoma Trial 0.215334 BRAF V600E 0.209967 Intergroup Melanoma Surgical 0.392563 AJCC melanoma 0.213393 early-stage melanoma 0.199906 Surg Oncol 0.350023 Melanoma Program Trial 0.312085 resected cutaneous melanoma 0.202183 Clin Oncol 0.748895 estadio iii 0.155762 Melanoma Study 0.201913 melanoma versus 0.218638 malignant melanoma 0.628871 metastatic melanoma harboring 0.204559 melanoma patients 0.202489 metastatic malignant melanoma 0.202173	CLICK HERE
1948	National Cancer Institute	Html	es	Tratamiento de los tumores extragonadales de células germinativas (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento de los tumores extragonadales de células germinativas.	siguientes grupos 0.500793 PDQ Tratamiento 0.447593 células madre 0.930362 presente sección 0.425406 pronóstico intermedio 0.514735 células germinativas seminomas 0.532192 células germinativas benignos 0.688648 tratamiento ensayos 0.59373 Physician Data Query 0.482499 coriónica humana beta 0.478909	alta dosis 0.47522 rayos x 0.439813 siguientes enlaces 0.419924 teratomas benignos 0.520514 National Cancer Institute 0.419632 tumores benignos 0.511502 marcadores tumorales afp 0.494552 siguientes riesgos 0.414221 siguientes sumarios 0.481053 Instituto Nacional 0.537154	CLICK HERE
1990	National Cancer Institute	Html	es	Comunicación en la atención del cáncer (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos sobre la comunicación con el paciente de cáncer y su familia, incluso los aspectos distintivos de la comunicación con pacientes de cáncer, los factores que afectan la comunicación y el entrenamiento de las aptitudes para la comunicación.	with breast 0.27121 patient communication research 0.255921 bad news 0.239568 Street RL Jr 0.270308 giving bad news 0.237103 Dukes KA 0.247903 difficult communication tasks 0.239533 informed consent 0.381629 Curr Opin Oncol 0.303353 patient decision-making 0.248603 Communication skills training 0.283908 American Society 0.336788 CA Cancer 0.26685 women with 0.382665 early breast 0.242745 Fallowfield L 0.241349 clinical trial 0.65623 cancer care 0.822992 Visser MR 0.248358 cancer patients 0.961853 Communication competency 0.236584 Oncology Educational Book 0.262112 Silliman RA 0.275555 patients with 0.301983 Baile WF 0.377394	patients with breast 0.241546 Cancer communication 0.28025 Patient-physician communication 0.262767 Soc Sci Med 0.536666 Patient Educ Couns 0.328692 Johnson Palensky JE 0.238609 Jenkins V 0.238673 Pediatr Blood Cancer 0.265712 Ong LM 0.251154 Clinical Oncology Educational 0.287455 National Cancer Institute 0.266416 with early-stage breast 0.27671 with patient satisfaction 0.238783 clinical oncology 0.509423 oncology clinical trials 0.240093 Sullivan LM 0.248063 Clin Oncol 0.716929 Thirty-Fourth Annual Meeting 0.246656 diagnosed breast patients 0.240688 patient satisfaction 0.273273 mujeres pacientes 0.274298 emotional health 0.24615 paciente capta 0.243139 Butow PN 0.59292	CLICK HERE
2065	National Cancer Institute	Html	es	Antecedentes de reproducción y riesgo de cáncer	Hoja informativa que describe lo que se sabe acerca de la relación entre el embarazo, el aborto espontáneo, el aborto provocado, el tratamiento de la fecundidad y el riesgo de cáncer.	receptor status 0.304466 long-term risk 0.309373 Pregnancy characteristics 0.303667 Pregnancy hormones 0.303713 case-control study 0.303107 reproductive factors 0.331813 British Journal 0.324023 Breast Cancer Research 0.395793 registry-based study 0.302906 risk factors 0.312191 collaborative reanalysis 0.305888 EPIC study 0.302933 population-based study 0.303204 Collaborative Group 0.305178 PubMed Abstract 0.987212 menor riesgo 0.316145 California Teachers Study 0.303614 maternal breast 0.310955 pregnancy is not 0.304559 altas concentraciones 0.302587 International Journal 0.309155 Reproductive Medicine 0.30288 Bernstein L 0.30839 temprana edad 0.305212 Titus-Ernstoff L 0.304113	after hormonal treatments 0.303615 Gynecologic Practice 0.305924 induced abortion 0.304146 mayores riesgos 0.303963 from epidemiological findings 0.304602 Hormonal Factors 0.309423 Endocrine-Related Cancer 0.31659 Hoover RN 0.3041 Mammary Gland Biology 0.302896 during pregnancy 0.303751 epidemiological studies 0.31198 subsequent risk 0.308543 prospective cohort study 0.304098 ACOG Committee Opinion 0.303117 Leeuwen FE 0.303776 breast cancer 0.953779 risk according 0.308782 pregnancy termination 0.303569 Romundstad PR 0.309387 vitro fertilization 0.304038 Colditz GA 0.304081 prospective study 0.303107 New England Journal 0.303804 systematic reviews 0.304009	CLICK HERE
3423	National Cancer Institute	Html	es	Tintes para el cabello y el riesgo de cáncer	Hoja informativa que analiza las investigaciones sobre la posible conexión entre los tintes para el cabello de uso personal y el cáncer.	Garcia-Closas M 0.306371 Harling M 0.306346 La Vecchia C 0.308404 American Medical Association 0.308091 Personal permanent 0.308814 Costantini AS 0.305724 pequeño aumento 0.306764 lymphoid neoplasms 0.305705 case-control study 0.330749 sustancias químicas llamadas 0.319289 linfoma no-Hodgkin 0.315605 IARC Monographs 0.307567 New England bladder 0.317677 dye products 0.311357 Benvenuti A 0.306313 Occupational Health 0.305772 Sanjose S 0.317218 Estados Unidos 0.315003 resultados contradictorios 0.358008 hematolymphopoietic malignancies 0.305757 PubMed Abstract 0.927635 on carcinogenicity 0.306299 International Agency 0.31736 International Journal 0.345823 análisis conjunto 0.313039	Nieters A 0.306464 Bolt HM 0.305479 Critical Reviews 0.305548 Nienhaus A 0.305624 leucemia aguda 0.319649 non-Hodgkin lymphoma 0.305903 is not 0.31478 Carcinogenic Risks 0.30569 aminas aromáticas 0.321464 Dulon M 0.30623 Epidemiology Biomarkers 0.309054 Thun MJ 0.305441 Etminan M 0.306466 Hamann CR 0.305758 determinados tipos 0.306529 Kogevinas M 0.306372 Aben KK 0.305435 Gago-Dominguez M 0.314868 Sandler DP 0.305457 case-control study from 0.31306 Some Aromatic Amines 0.30908 Schablon A 0.305625 Montes-Martinez A 0.305837 Decarli A 0.305736	CLICK HERE
3444	National Cancer Institute	Html	es	Exámenes de detección del cáncer de cavidad oral y orofaringe (PDQ®)–Versión para profesionales de salud	Sumario de información revisada por expertos sobre pruebas que se usan para detectar el cáncer de cavidad oral y orofaringe.	Ramadas K 0.326456 Sankaranarayanan R 0.337876 accessed march 0.331249 Zhang L 0.310727 Clinical Preventive Services 0.308765 Interim results from 0.307724 Sin embargo 0.381657 Kerr AR 0.312561 American Cancer Society 0.427439 Early findings from 0.308051 CA Cancer 0.323169 cluster randomized controlled 0.308479 oral pre-malignant 0.326412 oral cancer 0.913191 Preventive Services Task 0.376173 Instituto Nacional 0.317765 Cancer Res 0.323621 Human papillomavirus infection 0.307515 PDQ Exámenes 0.32226 oral cancer screening 0.566684 Estados Unidos 0.310609 Morton TH Jr 0.307383 Morton TH 0.311837 Epstein JB 0.323025 Database Syst Rev 0.307163	visual screening 0.315772 screening with 0.315479 upper aerodigestive tract 0.307566 SEER Cancer Statistics 0.324889 Cancer Society guidelines 0.325639 Trivandrum Oral Cancer 0.343561 carcinoma versus lesiones 0.311231 Jacob BJ 0.31089 potentially malignant disorders 0.308445 Cancer Facts 0.324242 Long term effect 0.3078 adjacent to clinically 0.307949 Oral Oncol 0.526329 oral verrucous 0.325426 National Cancer Institute 0.351683 center grapples with 0.307601 Oral Pathol Med 0.361585 Screening Study Group 0.316915 Am Dent Assoc 0.308416 Services Task Force 0.375429 Fluorescence visualization detection 0.308258 detección versus atención 0.319469 Brief Evidence Update 0.307856 Poh CF 0.312257	CLICK HERE
3567	National Cancer Institute	Html	en	NCI-Designated Cancer Centers	NCI-designated cancer centers are at the forefront of NCI-supported cancer research efforts at universities and cancer research centers across the United States.	Basic Laboratory Cancer 0.40308 cancer prevention 0.219474 United States 0.258952 promising laboratory discoveries 0.246618 successful investigator-initiated grants 0.242213 NCI grant funding 0.273266 cancer center investigators 0.372566 Cancer Centers conduct 0.328404 university medical centers 0.293855 research capabilities 0.206064 individual cancer center 0.29193 fosters cancer programs 0.290926 NCI Cancer Centers 0.39489 cutting-edge cancer treatments 0.306989	cancer research effort 0.342261 Comprehensive Cancer Centers 0.42681 NCI-Designated Cancer Center 0.361383 new treatments 0.264162 cancer patients 0.223724 cancer diagnosis 0.215839 basic laboratory research 0.296921 cancer centers 0.970403 substantial transdisciplinary research 0.27523 cancer clinical trials 0.286407 Laboratory Cancer Centers 0.418647 cancer survivors 0.215279 research studies 0.213208	CLICK HERE